IMNM vs GILD: Which Stock is Better?
Side-by-side comparison of Immunome Inc and Gilead Sciences Inc in 2026
IMNM
Immunome Inc
$22.90
GILD
Gilead Sciences Inc
$140.45
Key Metrics Comparison
| Metric | IMNM | GILD | Winner |
|---|---|---|---|
| Market Cap | $2.56B | $172.56B | GILD |
| P/E Ratio | N/A | 20.51 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | -1.0% | 0.0% | GILD |
| Gross Margin | -2454.2% | 78.8% | GILD |
Analyze IMNM
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMNM or GILD a better investment?
Comparing IMNM and GILD: Immunome Inc has a market cap of $2.56B while Gilead Sciences Inc has $172.56B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMNM and GILD?
IMNM (Immunome Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMNM or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMNM or GILD?
GILD has higher revenue growth at 0.0% vs -1.0% for IMNM.
Which company is more profitable: IMNM or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -2454.2% for IMNM.
Which is the larger company: IMNM or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $172.56B compared to $2.56B for IMNM.
Should I buy IMNM or GILD in 2026?
Both IMNM and GILD have investment merit. IMNM trades at $22.90 while GILD trades at $140.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMNM and GILD stock?
Key differences: Market Cap ($2.56B vs $172.56B), P/E Ratio (N/A vs 20.5x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (-2454.2% vs 78.8%).